Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase NA 3Phase 4 2Phase 2 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 13Terminated 6Recruiting 6Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Classical hematology 6Myeloid 1Gastrointestinal 1

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 45Neoplasms 44Multiple Myeloma 42Stomach Neoplasms 35Neoplasm Metastasis 32Leukemia, Myeloid, Acute 32Ovarian Neoplasms 31Lung Neoplasms 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Pancreatic Neoplasms 26Triple Negative Breast Neoplasms 25Recurrence 25Small Cell Lung Carcinoma 21Brain Neoplasms 21Esophageal Neoplasms 20Colonic Neoplasms 20Uterine Cervical Neoplasms 19Lymphoma, Large B-Cell, Diffuse 17Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

apixaban 2isoquercitrin 1Rivaroxaban 1N(4)-oleylcytosine arabinoside 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Venous Thromboembolism × Clear all
NCT07493304 2026-05-29

ROXI-CAT-II

Regeneron Pharmaceuticals

Phase 3 Recruiting
1,600 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07410117 2026-05-27

ROXI-CAT-I

Regeneron Pharmaceuticals

Phase 3 Recruiting
1,120 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT07005024 2026-02-05

DOAC

University of Vermont

Phase 3 Recruiting
996 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT06861088 2026-02-02

CATIQ P3

Quercis Pharma AG

Phase 3 Recruiting
480 enrolled
Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Thromboembolism, Venous Thrombosis, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Recruiting
1,828 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡